Serotype Distribution and Antimicrobial Susceptibility Profile of Streptococcus pneumoniae Among Myanmar Children with Acute Respiratory Infection
Thi Thi Htoon1*, Nan Aye Thida Oo2, Wah Wah Aung2, Hlaing Myat Thu2, Mon Mon3, Masaya Yamaguchi 4, Shigetada Kawabata4, Kyaw Zin Thant2
1National Health Laboratory, Ministry of Health and
Sports, Myanmar
2Department of Medical Research, Ministry of Health and
Sports, Myanmar
3University of Medicine (1), Ministry of Health and
Sports, Myanmar
4Department of Oral and Molecular Microbiology, Osaka University, Japan
*Corresponding author: Thi Thi Htoon, National Health Laboratory, Department of Medical Services, Ministry of Health and Sports, Myanmar. Tel: +9595138641; Email: thithihtoon@gmail.com
Received Date: 18 January, 2018; Accepted Date: 29 January, 2018; Published Date: 08 February, 2018
Citation: Htoon TT, Oo NAT, Aung WW, Thu HM, Mon M, et al. (2018) Serotype Distribution and Antimicrobial Susceptibility Profile of Streptococcus pneumoniae Among Myanmar Children with Acute Respiratory Infection. Int J Bacteriol Parasitol: IJBP-101. DOI: 10.29011/ IJBP-101. 000001
Background: Acute respiratory infection
(ARI) is the leading infectious cause of death in children younger than 5 years
of age worldwide. Streptococcus pneumoniae is the most frequent cause of
pneumonia in children aged less than 5 years worldwide.
Objective: The aim of this research
was to determine the capsular serotypes and antimicrobial susceptibility profile of Streptococcus pneumoniae strains isolated from children with ARI admitted to Yangon
Children Hospital (YCH).
Methods: A cross-sectional,
laboratory-based descriptive study was carried out on 231 ARI patients who were
aged 1 month to less than 5 years attending YCH from 2013 to 2015.
Nasopharyngeal swab specimens were taken after obtaining informed consent from
the parents or guardians of the patients. Antimicrobial susceptibility profile
was determined by modified Kirby-Bauer method. In addition, molecular
serotyping of S. pneumoniae was done by Sequential Multiplex
Polymerase Chain Reaction.
Results: The isolation rate of S. pneumoniae was 7.4% (17/231). A total of nine
different serotypes were detected. The most common serotype was found to be
6A/6B/6C/6D (52.9%) followed by non-typeable serotypes (29.4%), 19F, 23F and
35F/47F serotypes (11.8% each) and 23A, 11A/11D, 34 and 20 serotypes (5.9%
each). Carriage of multiple serotypes was observed in 29.4% of S. pneumoniae isolates. 70.6% of S. pneumoniae isolates were found to be
penicillin non-susceptible and multi-drug resistance was observed in 41.2% of
strains.
Conclusion: This study is among the
first to identify existing serotypes of S. pneumoniae from ARI children before
introduction of Pneumococcal Conjugate Vaccine (PCV) in National Immunization
Programme in Myanmar. These findings have highlighted the circulating serotypes
of S. pneumoniae strains and high occurrence of drug resistant S. pneumoniae isolates in Myanmar. Further larger studies on prevalent
pneumococcal serotypes after introduction of PCV is necessary to assess the
impact of immunization on preventing pneumococcal infection in Myanmar.
Keywords: Acute Respiratory Infection; Antimicrobial
Susceptibility; Children; Serotypes; Streptococcus pneumoniae
Acute Respiratory Tract Infections (ARIs) are among the leading causes of childhood mortality [1]. ARI mainly pneumonia is one of the six causes of death accounting for 17% of deaths among children younger than 5 years of age worldwide [2]. Myanmar is among 15 countries with the highest estimated absolute number of new cases of clinical pneumonia [1].
According to health statistics, the under-five mortality rate of
Myanmar children is 72 deaths per 1,000 live births [3]. Pneumonia is caused
by a number of infectious agents including bacteria, viruses and fungi. Among
them, the most common infectious agents of bacterial origin of clinical
pneumonia in developing countries include S. pneumoniae and Haemophilus influenzae type b [1].
Despite the introduction of Heptavalent Pneumococcal Conjugate Vaccine (PCV7), antimicrobial resistance in S. pneumoniae is still a serious concern worldwide especially in Asian countries. The estimated worldwide prevalence of penicillin-resistant S. pneumoniae (PRSP) was 14.1% and it was found to be much higher (30-40%) in southern Europe and Southeast Asia (exceeding 70%) [4].
In February 2017, World Health Organization has published its first list of 12 families of antibiotic-resistant ‘priority pathogens’ and penicillin non-susceptible S. pneumoniae is included in the medium priority list [5]. Multidrug Resistant S. pneumoniae (MRSP) has now become a public health problem in both developing and developed countries. A large multi-center study in Asian countries reported that the overall rate of Multidrug Resistance (MDR) in S. pneumoniae isolates was 59.3% and the highest MDR rate is found in China, followed by Vietnam, South Korea, Hong Kong, and Taiwan [6].
Identification of the capsular serotypes of S. pneumoniae is important not only for surveillance programs but also for evaluation of the effect of vaccination on nasopharyngeal carriage [7]. Accurate determination of pneumococcal serotypes is critically important since the vaccine development presently relies on serotype prevalence data [8].
In most developing countries, PCVs are not routinely used
because of their high costs and lack of data regarding the burden of the
disease. Despite the importance of the S. pneumoniae, there have not been any previous published
studies regarding detailed epidemiological information on pneumococcal
serotypes in Myanmar.
The information on circulating capsular serotypes of S. pneumoniae among children aged
less than 5 years is important since it provides baseline information about
disease epidemiology before introduction of PCV in Myanmar.
The aim of this study was to characterize S. pneumoniae strains isolated from
nasopharyngeal swab specimens of children with acute respiratory infection
admitted to Yangon Children Hospital from 2013 to 2015.
1. Material and Methods
A cross-sectional, laboratory-based descriptive study was
carried out on 231 ARI patients (135 males, 58.4% and 96 females, 41.6%) who
were aged 1 month to less than 5 years (Median age = 12.5 months) from 2013 to
2015. All patients aged 1month to <5 years with clinically diagnosed
ARI and admitted to Yangon Children Hospital were selected. Severely ill ARI
patients and ARI patients who have received parental antibiotics beyond first
24 hours after admission were excluded from the study.
Out of 231 ARI patients, 135 cases (58.4%) were male
children and 96 cases (41.6%) were females. Majority of the ARI patients
(195/231, 84%) were less than 2 years of age. The youngest patient was 1 month
old and the oldest one was 4 years and 10 months.
Concerning the different clinical conditions of ARI patients,
severe pneumonia was the most commonly diagnosed clinical condition (101/231,
43.7%) followed by bronchiolitis (86/231, 37.2%) and severe bronchiolitis
(28/231, 12.1%). Pneumonia was diagnosed in 15 patients (6.5%) and very severe
pneumonia was noted in only one patient (0.4%).
Nasopharyngeal swab specimens were taken using a sterile Dacron
swab after
obtaining informed consent from the parents or guardians of the patients and were placed
in normal saline and
transported to the laboratory at Department of Medical Research, Yangon.
Each swab was placed in Skim-Milk Tryptone Glucose Glycerol (STGG) medium and was inoculated onto blood agar and incubated in a CO2-enriched atmosphere at 37°C overnight. S. pneumoniae was identified by characteristic alpha-hemolytic colonial morphology and Gram stained smear showing lancet-shaped gram-positive diplococci. Confirmation of S. pneumoniae was made by biochemical tests such as optochin susceptibility test and bile solubility test [9].
1.1. Identification of the serotypes of S. pneumoniae
Nasopharyngeal samples in normal saline were boiled at 100°C for 10 minutes and stored at-20°C until PCR was
performed. These samples were
transported to Department of Oral and Molecular Microbiology, Osaka
University Graduate School of Dentistry, Osaka, Japan where Sequential
Multiplex Polymerase Chain Reaction (PCR) was performed. Boiled nasopharyngeal samples in normal saline were
used as DNA template. Each multiplex PCR reaction was designed to sequentially
include primer pairs targeting serotype-specific regions of the most frequently
occurring serotypes [10].
Forty-one serotype-specific primer pairs were grouped into eight
sets for sequential testing. Forty-one primer pairs were used to target
serotypes 1, 2, 3, 4, 5, 6A/6B/6C/6D, 7C/7B/40, 7F/7A, 8, 9N/9L, 9V/9A, 10A,
10F/10C/33C, 11A/11D, 12F/12A/12B/44/46, 13, 14, 15A/15F, 15B/15C, 16F, 17F,
18C/18F/18B/18A, 19A, 19F, 19Fvar, 20, 21, 22F/22A, 23A, 23B, 23F, 24F/24A/24B,
31, 33F/33A/37, 34, 35A/35C/42, 35B, 35F/47F, 38/25F/25A, and 39. A primer pair
pneumococcal capsular polysaccharide synthesis gene (primers cpsA-f and cpsA-r)
was also included as the positive control targeting the cpsA locus
found in all 93 known serotypes of S. pneumoniae [11].
The reaction mixtures were amplified in a DNA thermal cycler and
run under
the following amplification conditions for all eight reactions: initial
denaturation at 95°C for 15 min followed by 35 amplification cycles of 94°C for 30 secs, 54°C for 90 secs, 72°C for 60 secs and a final extension
step at 72°C for 10 min. The amplified products were analyzed by
electrophoresis in 3% agarose gel using ethidium bromide and the DNA bands were
visualized in ultraviolet transilluminator.
Antimicrobial Susceptibility Testing of S. pneumoniae
Antimicrobial susceptibility profile of culture-confirmed S. pneumoniae isolates was
determined by modified Kirby-Bauer method on Mueller-Hinton agar medium supplemented
with 5% horse blood according to the performance
standards of Clinical and Laboratory Standards Institute (CLSI) [12]. Fourteen
antibiotic discs (HiMedia) containing oxacillin (1μg), ampicillin (10μg), amoxicillin-clavulanic
acid (30μg), cloxacillin
(1μg), flucloxacillin
(5μg), cefotaxime
(30μg), ceftriaxone
(30μg), erythromycin
(15μg), azithromycin (15μg), ciprofloxacin (5μg), levofloxacin
(5μg), vancomycin
(30μg), co-trimoxazole
(25μg) and gentamicin
(10 μg) were used. Then, CLSI zone size
interpretation chart was used to identify as resistant, intermediate or
susceptible S. pneumoniae isolates.
2. Data Analysis
After collection of data, data entry, data editing, data
cleansing, data compilation, data processing and data analysis were done using
appropriate statistical software, SPSS version 16.0.
3. Ethical Consideration
Approval to conduct this study was obtained from the Research
and Ethical Committee of University of Medicine 1, Yangon on 10.10.2013.
4. Results
Streptococcus pneumoniae was isolated from 7.4 % of total cases
(17/231).
A total of nine different serotypes were detected. The most common
serotype was found to be 6A/6B/6C/6D (9 isolates, 52.9%) followed by
non-typeable serotype (5 isolates, 29.4%), 19F, 23F and 35F/47F serotypes (2
isolates, 11.8% each) and 23A, 11A/11D, 34 and 20 serotypes (1 isolate, 5.9%
each). (Figure 1).
In this study, 70.6% of S. pneumoniae isolates (n=12) were detected as carrying single serotype
(non-typeable serotypes-5 isolates, 6A/B/C/D- 4 isolates, 19F, 23F and 23A- 1
isolate each).
Carriage of multiple serotypes was observed in 5 S. pneumoniae isolates. Four
isolates (23.5%) were found carrying two serotypes in different combination
(6A/B/C/D + 11A/11D, 6A/B/C/D + 19F, 6A/B/C/D + 34 and 6A/B/C/D + 35F/47F).
Carriage of four serotypes (6A/B/C/D + 20 + 23F + 35F/47F) was found in only
one isolate (5.9%) (Table 1).
Antibiotic Susceptibility Determined by Modified Kirby-Bauer
Method
Most of the S. pneumoniae isolates showed high sensitivity to injection form antibiotics
like cefotaxime and ceftriaxone and also to oral antibiotics like levofloxacin,
vancomycin, cloxacillin, flucloxacillin and azithromycin. It was also observed
that these isolates were highly resistant to oral antibiotics like
co-trimoxazole, oxacillin and ampicillin. Oral and parenteral penicillin are
commonly used antibiotics in the current treatment of ARI and Penicillin
Resistant S. pneumoniae (PRSP) was found in 12 isolates (70.6%) (Figure 2).
S. pneumoniae strains that were intermediate resistant or resistant to at least 3 or more antibiotics of
different classes prescribed in current treatment regimen namely: penicillin,
cefotaxime, ceftriaxone, cotrimoxazole, erythromycin and ciprofloxacin were
analyzed. A total of 7 MRSP strains were detected among the drug resistant
isolates (Table
2).
5. Discussion
In this study, the incidence of ARI was found to be higher among
the children who were less than 2 years of age (n=195, 84%), a rate comparable
with studies in Malaysia (76%) and in Bangladesh (87.9%) [13,14]. The occurrence of
ARI was found to be higher in male children (58.4%) in the present study that
was consistent with other recent international reports from Brazil (52.8%),
Bangladesh (62.5%) and previous local study showing 56% (ranging from 52.8%
to 62.5%) [14-16].
The prevalence of S. pneumoniae in Myanmar is closely linked to neighboring countries within
South East Asia region and other Asian countries. The culture positivity rate
of 7.4 % obtained in this study was nearly the same rate identified in
Bangladesh (7%) [17]. However, in comparison with that of Philippines, Thailand and
previous study in Myanmar (51%, 34.5% and 30%respectively), it was relatively
very low [16,18,19]. This low isolation
rate of S. pneumoniae may be due to prior use of oral antibiotics at home and prior
parenteral antibiotic therapy on admission of the patients.
In this study, oral penicillin (amoxicillin) was prescribed in
two S.
pneumoniae infected patients (11.8%) while only one patient (5.9%) have
received oral sulphonamides (co-trimoxazole) before the collection of
nasopharyngeal swab specimens. Regarding the prior therapy with parenteral
antibiotics, only four out of 17 S. pneumoniae infected patients (23.6%) were prescribed with intravenous
penicillin within first 24 hours after admission before the collection of
specimens. It was found that isolation rate of S. pneumoniae was higher in patients
who have not received prior therapy with oral or parenteral antibiotics before
the collection of specimens.
In our collection of isolates, which was in agreement with
recent reports from other South East Asian countries like Singapore, Malaysia,
China and Thailand-Myanmar Border that serotype 6A/6B/6C/6D, 19F and 23F were
among the most common serotypes [20-23]. Co-colonization of multiple pneumococcal serotypes is another
emerging epidemiological concern as it may have an influence on the efficacy of
pneumococcal vaccines [24,25]. The carriage rate of multiple serotypes in
this study (n=5, 29.4%) was relatively high when compared to that of study at
Thailand-Myanmar Border (5.1%) [23].
Interestingly, recently emerged serotype 19A, the frequently
detected nonvaccine serotype was not identified probably because of the small
size of isolated pneumococcal strains (n=17) that fails to show significant
predominance of the frequency of serotypes and pneumococcal vaccines have not
been introduced yet in Myanmar. Introduction of Pneumococcal Conjugate Vaccine
(PCV) in National Immunization Programme was launched in July 2016 in
Myanmar.
The prevalence rates of antibiotic-resistant and
non-susceptible S. pneumoniae have increased in South East Asia over recent decades like in
many other countries worldwide [26]. In India, the rate of reduced susceptibility of S. pneumoniae strains to penicillin
was reported as only 4.9% which is very low when compared to a high rate
(70.6%) of penicillin-resistant pneumococci in Myanmar [27]. Another national
antimicrobial resistance survey conducted in Thailand demonstrated that
country-wide penicillin resistance rate of the pneumococcal isolates was 37.2%
that was lower than our data [19].
In comparison to the previous study conducted in Myanmar by Tin Nwe Oo, the rate of sensitivity to penicillin was markedly decreased from 60% in 2008 to 29.4% in 2015 [16]. Data from the present study have indicated a high rate (70.6%) of penicillin-resistant pneumococci among ARI children in Myanmar. This was probably due, in part, to the easily availability of antibiotics and lack of an antibiotic policy in the country.
Multidrug resistance was defined as intermediate resistance or
resistance to penicillin plus intermediate resistance or resistance to ≥2 antimicrobial agents
of different classes [28]. In this study, 41.2% of S. pneumoniae strains were found to be multidrug resistant (MDR) which was in
accordance with data from Northern Palestine (49%), Vietnam (45%) and Korea
(45.2%) [26,29,30]. However,
the rate of MDR strains in the present study was relatively high when compared
with data from India (5.3%) [26]. Increased rate of multi-drug resistant S. pneumoniae strains in this study
might be due to availability of oral antibiotics without prescription of the
medical doctors and indiscriminate use of antibiotics leading to emergence of
drug-resistant strains in the community and hospitals.
Strategies for prevention of pneumococcal pneumonia include
treatment with appropriate antimicrobial therapy and immunization with
currently available pneumococcal conjugate vaccines. Although this study
characterized only a relatively small number of isolates from one center, it
can firstly demonstrate the presence of previously unreported information of
circulating capsular serotypes of S. pneumoniae before introduction of pneumococcal vaccine. However, the
present study was unable to show significant predominance of the frequency of
serotypes because of the small sample size.
In conclusion, the findings from the present study have
highlighted the high incidence of penicillin nonsusceptible and multidrug
resistant S. pneumoniae isolates among the Myanmar population. In addition, there is an
urgent need of a long-term surveillance system to monitor the distribution of
capsular serotypes of S. pneumoniae among pediatric population of Myanmar or to detect the
serotypes implicated in pneumococcal disease cases.
6. Acknowledgement
I am greatly indebted to Professor. Shigetada Kawabata and Dr.
Masaya Yamaguchi, Assistant Professor, Department of Oral and Molecular
Microbiology, Osaka University Graduate School of Dentistry, Osaka, Japan for
their kind invaluable supervision and allowing me to utilize the research
facilities for molecular diagnostic work in March 2015.
Figure 1: Proportion
of capsular serotypes of isolated S. pneumoniae.
Plate (1) Detection of Serotype 35F/47F (517bp) by
Sequential Multiplex PCR (6): Lane 1 and 19 (M): showing 100 base pair
DNA ladder marker. Lane 2 to 18 - Sample 1 to Sample 17. Lane 3 and 4 - (Sample
2 and 3) showing 517 bp bands indicating serotype 35F/47F. CPSA - showing 160bp
bands indicating internal positive control
Figure 2: Antibiotic susceptibility pattern of S. pneumoniae isolates determined by modified Kirby-Bauer method.
Primer pair |
Primer sequence (5' →3') |
Product size (bp) |
1-f 1-r |
CTC TAT AGA ATG GAG TAT ATA AAC TAT GGT TA CCA AAG AAA ATA CTA ACA TTA TCA CAA TAT TGG C |
280 |
2-f 2-r |
TAT CCC AGT TGA ATA TTT CTC CAC TAC ACC ACA CAA AAT ATA GGC AGA GAG AGA CTA CT |
290 |
3-f 3-r |
ATG GTG TGA TTT CTC CTA GAT TGG AAA GTA G CTT CTC CAA TTG CTT ACC AAG TGC AAT AAC G |
371 |
4-f 4-r |
CTG TTA CTT GTT CTG GAC TCT CGA TAA TTG G GCC CAC TCC TGT TAA AAT CCT ACC CGC ATT G |
430 |
5-f 5-r |
ATA CCT ACA CAA CTT CTG ATT ATG CCT TTG TG GCT CGA TAA ACA TAA TCA ATA TTT GAA AAA GTA TG |
362 |
6A/6B/6C/6D*-f 6A/6B/6C/6D-r |
AAT TTG TAT TTT ATT CAT GCC TAT ATC TGG TTA GCG GAG ATA ATT TAA AAT GAT GAC TA |
250 |
6C/6D-f 6C/6D-r |
CAT TTT AGT GAA GTT GGC GGT GGA GTT AGC TTC GAA GCC CAT ACT CTT CAA TTA |
727 |
7C/7B/40-f 7C/7B/40-r |
CTA TCT CAG TCA TCT ATT GTT AAA GTT TAC GAC GGG A GAA CAT AGA TGT TGA GAC ATC TTT TGT AAT TTC |
260 |
7F/7A-f 7F/7A-r |
TCC AAA CTA TTA CAG TGG GAA TTA CGG ATA GGA ATT GAG ATT GCC AAA GCG AC |
599 |
8-f 8-r |
GAA GAA ACG AAA CTG TCA GAG CAT TTA CAT CTA TAG ATA CTA GTA GAG CTG TTC TAG TCT |
201 |
9N/9L-f 9N/9L-r |
GAA CTG AAT AAG TCA GAT TTA ATC AGC ACC AAG ATC TGA CGG GCT AAT CAA T |
516 |
9V/9A-f 9V/9A-r |
GGT GTA GAT TTA CCA TTA GTG TCG GCA GAC CCA TGA ATG AAA TCA ACA TTG TCA GTA GC |
816 |
10A-f 10A-r |
GGT GTA GAT TTA CCA TTA GTG TCG GCA GAC GAA TTT CTT CTT TAA GAT TCG GAT ATT TCT C |
628 |
10F/10C/33C-f 10F/10C/33C-r |
GGA GTT TAT CGG TAG TGC TCA TTT TAG CA CTA ACA AAT TCG CAA CAC GAG GCA ACA |
248 |
11A/11D-f 11A/11D-r |
GGA CAT GTT CAG GTG ATT TCC CAA TAT AGT G GAT TAT GAG TGT AAT TTA TTC CAA CTT CTC CC |
463 |
12F/12A/12B/44/46-f 12F/12A/12B/44/46-r |
GCA ACA AAC GGC GTG AAA GTA GTT G CAA GAT GAA TAT CAC TAC CAA TAA CAA AAC |
376 |
13-f 13-r |
TAC TAA GGT AAT CTC TGG AAA TCG AAA GG CTC ATG CAT TTT ATT AAC CGC TTT TTG TTC |
655 |
14-f 14-r |
GAA ATG TTA CTT GGC GCA GGT GTC AGA ATT GCC AAT ACT TCT TAG TCT CTC AGA TGA AT |
189 |
15A/15F-f 15A/15F-r |
ATT AGT ACA GCT GCT GGA ATA TCT CTT C GAT CTA GTG AAC GTA CTA TTC CAA AC |
434 |
15B/15C-f 15B/15C-r |
TTG GAA TTT TTT AAT TAG TGG CTT ACC TA CAT CCG CTT ATT AAT TGA AGT AAT CTG AAC C |
496 |
16F-f 16F-r |
GAA TTT TTC AGG CGT GGG TGT TAA AAG CAG CAT ATA GCA CCG CTA AGC AAA TA |
717 |
17F-f 17F-r |
TTC GTG ATG ATA ATT CCA ATG ATC AAA CAA GAG GAT GTA ACA AAT TTG TAG CGA CTA AGG TCT GC |
693 |
18C/18F/18B/18A-f 18C/18F/18B/18A -r |
CTT AAT AGC TCT CAT TAT TCT TTT TTT AAG CC TCT GTA AAC CAT ATC AGC ATC TGA AAC |
573 |
19A-f 19A-r |
GAG AGA TTC ATA ATC TTG CAC TTA GCC A CAT AAT AGC TAC AAA TGA CTC ATC GCC |
566 |
19F-f 19F-r |
GTT AAG ATT GCT GAT CGA TTA ATT GAT ATC C GTA ATA TGT CTT TAG GGC GTT TAT GGC GAT AG |
304 |
19Fvar-f 19Fvar-r |
GAC AAT TCT GGT TGA CTT GTT GAT TTT G CTA CCA AAT ACC TCA CCA GCT TCC |
585 |
20-f 20-r |
GAG CAA GAG TTT TTC ACC TGA CAG CGA GAA G CTA AAT TCC TGT AAT TTA GCT AAA ACT CTT ATC |
514 |
21F-f 21F-r |
CTA TGG TTA TTT CAA CTC AAT CGT CAC C GGC AAA CTC AGA CAT AGT ATA GCA TAG |
192 |
22F/22A-f 22F/22A-r |
GAG TAT AGC CAG ATT ATG GCA GTT TTA TTG TC CTC CAG CAC TTG CGC TGG AAA CAA CAG ACA AC |
643 |
23A-f 23A-r |
TAT TCT AGC AAG TGA CGA AGA TGC G CCA ACA TGC TTA AAA ACG CTG CTT TAC |
722 |
23B-f 23B-r |
CCA CAA TTA GCG CTA TAT TCA TTC AAT CG GTC CAC GCT GAA TAA AAT GAA GCT CCG |
199 |
23F-f 23F-r |
GTA ACA GTT GCT GTA GAG GGA ATT GGC TTT TC CAC AAC ACC TAA CAC ACG ATG GCT ATA TGA TTC |
384 |
24F/24A/24B-f 24F/24A/24B -r |
GCT CCC TGC TAT TGT AAT CTT TAA AGA G GTG TCT TTT ATT GAC TTT ATC ATA GGT CGG |
99 |
31-f 31-r |
GGA AGT TTT CAA GGA TAT GAT AGT GGT GGT GC CCG AAT AAT ATA TTC AAT ATA TTC CTA CTC |
701 |
33F/33A/37-f 33F/33A/37-r |
GAA GGC AAT CAA TGT GAT TGT GTC GCG CTT CAA AAT GAA GAT TAT AGT ACC CTT CTA C |
338 |
34-f 34-r |
GCT TTT GTA AGA GGA GAT TAT TTT CAC CCA AC CAA TCC GAC TAA GTC TTC AGT AAA AAA CTT TAC |
408 |
35A/35C/42-f 35A/35C/42-r |
ATT ACG ACT CCT TAT GTG ACG CGC ATA CCA ATC CCA AGA TAT ATG CAA CTA GGT T |
280 |
35B-f 35B-r |
GAT AAG TCT GTT GTG GAG ACT TAA AAA GAA TG CTT TCC AGA TAA TTA CAG GTA TTC CTG AAG CAA G |
677 |
35F/47F-f 35F/47F-r |
GAA CAT AGT CGC TAT TGT ATT TTA TTT AAA GCA A GAC TAG GAG CAT TAT TCC TAG AGC GAG TAA ACC |
517 |
38/25F/25A-f 38/25F/25A -r |
CGT TCT TTT ATC TCA CTG TAT AGT ATC TTT ATG ATG TTT GAA TTA AAG CTA ACG TAA CAA TCC |
574 |
39F-f 39F-r |
TCA TTG TAT TAA CCC TAT GCT TTA TTG GTG GAG TAT CTC CAT TGT ATT GAA ATC TAC CAA |
98 |
cpsA-f cpsA-r |
GCA GTA CAG CAG TTT GTT GGA CTG ACC GAA TAT TTT CAT TAT CAG TCC CAG TC |
160 |
*All serotypes that are co-detected are listed |
List of oligonucleotide primers used for pneumococcal serotype deduction by conventional multiplex PCR (SIGMA-ALDRICH).
Number of detected serotypes |
Number of isolates |
Percentage (%) |
1 serotype |
12/7 |
70.6% |
2 serotypes |
4/17 |
23.5% |
4 serotypes |
1/17 |
5.9% |
Table 1: Detection of different number of serotypes of isolated S. pneumoniae.
Resistant antibiotics |
No of S. Pneumoniae isolates |
Total |
P + E + Ci + Co |
3 |
7 |
P + E + Ce |
1 |
|
P + E + Cef |
1 |
|
P + E + Co |
2 |
|
P= Penicillin Co= Cotrimoxazole Ce= Cefotaxime E= Erythromycin Ci= Ciprofloxacin Cef= Ceftriaxone |
Table 2: Drug resistant pattern of S. pneumoniae showing multiple resistance to antibiotics.
- Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H (2008) Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86: 408-416.
- World Health Organization (2008). Acute Respiratory Infections in children. http://www.who.int/vaccineresearch/diseases/ari/en/index3.html
- Myanmar National Health Plan 2017-2021 (2016) Ministry of Health and Sports. The Republic of the Union of Myanmar.
- Felmingham D, Gruneberg RN (2000) The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45: 191-203.
- World Health Organization (2017) Global Priority List of antibiotic-resistant bacteria to guide Research, Discovery, and Development of new antibiotics.
- Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, et al. (2012) Changing Trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 56: 1418-1426.
- Klugman KP (2001) Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. The Lancet Infect Dis 1: 85-91.
- Hausdorff WP, Bryant J, Paradiso PR, Siber GR (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30: 100-121.
- World Health Organization (2003) Manual for the
laboratory identification and antimicrobial susceptibility testing of bacterial
pathogens of public health importance in the developing world. Publication no. WHO/CDS/CSR/EPH/ 2002.15.
- da Gloria Carvalho M, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, et al. (2010) Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 48: 1611-1618.
- Mavroidi A, Godoy D, Aanensen DM, Robinson DA, Hollingshead SK, et al. (2004) Evolutionary genetics of the capsular locus of serogroup 6 pneumococci. Journal of Bacteriology 186: 8181-8192.
- Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Wayne, USA.
- Lim LH, Lee WS, Parasakthi N (2007) Childhood invasive pneumococcal disease: a hospital-based study from Malaysia. J Paediatr Child Health 43: 366-369.
- Baqui AH, Rahman M, Zaman K, Arifeen SE, Chowdhury HR, et al (2007) A population-based study of hospital admission incidence rate and bacterial aetiology of acute lower respiratory infections in children aged less than five years in Bangladesh. J Health Popul Nutr 25: 179-188.
- Mantese OC, Paula Ad, Almeida VV, Aguiar PA, Wolkers PC, et al. (2009) Prevalence of serotypes and antimicrobial resistance of invasive strains of pneumococcus in children: analysis of 9 years. J Pediatr 85: 495-502.
- Tin-Nwe-Oo (2008) Bacteriological and antimicrobial
susceptibility profile of acute respiratory tract infections in Yangon Children
Hospital. M.Med.Sc (Microbiology) Thesis, University of Medicine 1, Yangon.
- International Centre for Diarrhoeal Disease Research,
Bangladesh (2000) Health and demographic surveillance system-Matlab.
Registration of demographic events and contraceptive use, 1998. Dhaka (ICDDR, B
scientific report no. 87) 31: 84.
- Lankinen
KS, Leinonen M, Tupasi TE, Haikal R, Ruutu P (1994) Pneumococci in
nasopharyngeal samples from Filipino children with acute respiratory
infections. J Clin Microbiol 32: 2948-2952.
- Dejsirilert S, Overweg K, Sluijter M, Saengsuk L, Gratten M, et al. (1999) Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children with acute respiratory tract infections in Thailand: a molecular epidemiological survey. J Clin Microbiol 37: 1832-1838.
- Jauneikaite E, Jefferies JMC, Churton NWV, Lin RTP, Hibberd ML, et at. (2014) Genetic diversity of Streptococcus pneumoniae causing meningitis and sepsis in Singapore during the first year of PCV7 implementation. Emerg Microbes and Infect 3: e39.
- Le CF, Palanisamy NK, Yusof MYM, Sekaran SD (2011) Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia 6: e19547.
- Xue L, Yao K, Xie G, Zheng Y, Wang C, et al. (2010) Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates That Cause Invasive Disease among Chinese Children. Clin Infect Dis 50: 741-744.
- Turner P, Turner C, Jankhot A, Helen N, Lee SJ, et al. (2012) A Longitudinal Study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border. 7: e38271.
- Rivera-Olivero IA, Blommaart M, Bogaert D, Hermans PW, de Waard JH (2009) Multiplex PCR reveals a high rate of nasopharyngeal pneumococcal 7-valent conjugate vaccine serotypes co-colonizing indigenous Warao children in Venezuela. J Med Microbiol 58: 584-587.
- Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962-1973.
- Song JH, Chang HH, Suh JY, Ko KS, Jung SI, et al. (2004) Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 53: 457-463.
- Molander V, Elisson C, Balaji V, Backhaus E, John J, et al. (2013) Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes. BMC Infect Dis 13:532.
- Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, Canueto-Quintero J, Sanchez-Porto A, et al. (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 24: 1052-1059.
- Parry CM, Duong NM, Zhou J, Mai NTH, Diep TS, et al. (2002) Emergence
in Vietnam of Streptococcus pneumoniae resistant to multiple antimicrobial agents as a result
of dissemination of the multiresistant Spain23F-1 clone. Antimicrob Agents Chemother 46:3512–3517.
- Adwan K, Abu-Hasan N, Hamdan A, Al-Khalili S (1999) High incidence of penicillin resistance amongst clinical isolates of Streptococcus pneumoniae in northern Palestine. J Med Microbiol 48: 1107-1110.